Real-time enrollment status for this primary immunodeficiency clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:56 AM UTC
| NCT Number | NCT03610802 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiency |
| Phase | Clinical Trial |
| Target Enrollment | 3,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | June 24, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT03610802 is currently recruiting participants. This clinical trial study for primary immunodeficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03610802 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03610802 was last updated 2 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.